Award
NIH Reporter #1R01AI198553-01
Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infections
Recipient
National Institute of Allergy and Infectious Diseases (NIAID)
Award Amount
$463,290.00
Ceiling
$463,290.00
Awarded
June 25, 2026
Identifier
1R01AI198553-01
Award for research on targeting GAPM3 protein to treat acute and chronic Toxoplasma gondii infections, funded by NIAID.
Description
This project aims to evaluate the efficacy of targeting the membrane protein GAPM3 in Toxoplasma gondii infections, addressing a major unmet need for new therapeutics against toxoplasmosis.